Does continuous glucose monitoring reduce Hypoglycemia in ICU patients?

In intensive care units (ICUs), managing blood sugar levels is a critical task, especially for patients receiving continuous insulin therapy. While standard practice often relies on point-of-care (POC) testing—which involves taking a blood sample at specific intervals—newer technologies like continuous glucose monitoring (CGM) provide real-time data. The question is whether using these continuous monitors instead of intermittent tests helps prevent low blood sugar, known as hypoglycemia.

What the research says

A systematic review of 18 randomized clinical trials involving over 2,000 patients found that using CGM instead of POC testing may reduce the risk of hypoglycemia in ICU patients. However, the researchers noted that the certainty of this evidence is very low ².

Despite the uncertainty in the data, some experts suggest that CGM may have an advantage over POC testing because it provides glucose values every 5 to 10 minutes. This constant stream of data can show the direction and rate of change in a patient's blood sugar, which may help clinicians manage insulin more effectively and reduce the risk of severe hypoglycemia ⁷.

In the ICU setting, the shift toward CGM technology has also been explored as a way to manage patients with hyperglycemia (high blood sugar) while reducing the need for frequent, direct contact between healthcare providers and patients ⁶.

What to ask your doctor

• How does the hospital currently monitor blood sugar for patients in the ICU?
• What are the specific benefits of using continuous glucose monitoring (CGM) over point-of-care testing for preventing hypoglycemia?
• Is there enough evidence to support the use of CGM as a primary tool for preventing low blood sugar in critical care?
• How does real-time data on the rate of change in blood sugar help in making treatment decisions?